An experimental vaccine against the chronic liver disease hepatitis C has shown promising results in its first clinical trial in humans, say researchers from the University of Oxford, UK, who write about their findings in the 4 January online issue of Science Translational Medicine. However, they caution there is still a long way to go before we have an effective vaccine ready for clinical use. There is currently no vaccine for hepatitis C virus (HCV), a major pathogen transmitted through the blood that infects some 170 million people around the world...
More...
More...